22 July 2022 : Database Analysis
Role of Serum Creatinine Levels in Prognostic Risk Stratification of Prostate Cancer Patients
Xingbo Gu1ACDEFG*, Jiaojiao Wu1BCDEF, Xuefeidan Liu2AD, Yun Hong1BCDF, Yaoxi Wu3AD, Ye Tian1ADDOI: 10.12659/MSM.937100
Med Sci Monit 2022; 28:e937100
Table 3 Odds ratio and 95% confidence interval of high risk of prostatic cancer according to quintiles of creatinine: subgroup analyses.
| Subgroups | Serum creatinine (umol/L) | P-interaction | ||||
|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | Q5 | ||
| Age, years | 0.824 | |||||
| <67 (medium) | 3.60 (0.94–1.39) | Ref | 4.18 (1.05–1.66) | 2.60 (0.63–1.08) | 5.73 (1.44–2.28) | |
| ≥67 | 5.81 (1.55–21.72) | Ref | 5.45 (1.47–20.19) | 6.39 (1.80–22.68) | 6.07 (1.68–21.94) | |
| BMI, kg/m | 0.129 | |||||
| <24 | 6.16 (1.29–29.37) | Ref | 7.34 (1.57–34.20) | 5.13 (1.04–25.36) | 3.30 (0.59–18.59) | |
| ≥24 | 4.31 (1.30–14.25) | Ref | 3.00 (0.87–10.34) | 4.16 (1.32–13.13) | 6.64 (2.15–20.49) | |
| Except for stratified variables, all variables are adjusted according to Model 3 in . | ||||||